Medicare proposes covering expensive Alzheimer's drug for those in clinical trials
Aduhelm is the first treatment approved in the country to slow cognitive decline in those living with Alzheimer's. Doctors have refused to prescribe it, given the lack of data and evidence behind it.
Read more on NPR
Làm đẹp Blog 247 January 12, 2022 at 07:55AM
Category Science
Không có nhận xét nào:
Đăng nhận xét